217 related articles for article (PubMed ID: 24785509)
41. A Preliminary Study on Racial Differences in HMOX1, NFE2L2, and TGFβ1 Gene Polymorphisms and Radiation-Induced Late Normal Tissue Toxicity.
Alam A; Mukhopadhyay ND; Ning Y; Reshko LB; Cardnell RJ; Alam O; Rabender CS; Yakovlev VA; Walker L; Anscher MS; Mikkelsen RB
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):436-43. PubMed ID: 26238954
[TBL] [Abstract][Full Text] [Related]
42. Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients.
Schack LMH; Petersen SE; Nielsen S; Lundby L; Høyer M; Bentzen L; Overgaard J; Andreassen CN; Alsner J
Acta Oncol; 2017 Nov; 56(11):1514-1521. PubMed ID: 28844157
[TBL] [Abstract][Full Text] [Related]
43. Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study.
Hishida A; Nakatochi M; Tamura T; Nagayoshi M; Okada R; Kubo Y; Tsukamoto M; Kadomatsu Y; Suzuki S; Nishiyama T; Kuriyama N; Watanabe I; Takezaki T; Nishimoto D; Kuriki K; Arisawa K; Katsuura-Kamano S; Mikami H; Kusakabe M; Oze I; Koyanagi YN; Nakamura Y; Kadota A; Shimanoe C; Tanaka K; Ikezaki H; Murata M; Kubo M; Momozawa Y; Takeuchi K; Wakai K;
Nagoya J Med Sci; 2021 Feb; 83(1):183-194. PubMed ID: 33727749
[TBL] [Abstract][Full Text] [Related]
44. Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.
Kerns SL; Stock RG; Stone NN; Blacksburg SR; Rath L; Vega A; Fachal L; Gómez-Caamaño A; De Ruysscher D; Lammering G; Parliament M; Blackshaw M; Sia M; Cesaretti J; Terk M; Hixson R; Rosenstein BS; Ostrer H
Radiother Oncol; 2013 Jun; 107(3):372-6. PubMed ID: 23719583
[TBL] [Abstract][Full Text] [Related]
45. Rare coding variants and breast cancer risk: evaluation of susceptibility Loci identified in genome-wide association studies.
Zhang Y; Long J; Lu W; Shu XO; Cai Q; Zheng Y; Li C; Li B; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):622-8. PubMed ID: 24470074
[TBL] [Abstract][Full Text] [Related]
46. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
[TBL] [Abstract][Full Text] [Related]
47. Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity.
Quon H; Cheung PC; Loblaw DA; Morton G; Pang G; Szumacher E; Danjoux C; Choo R; Thomas G; Kiss A; Mamedov A; Deabreu A
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):898-905. PubMed ID: 21237581
[TBL] [Abstract][Full Text] [Related]
48. Hints of hidden heritability in GWAS.
Gibson G
Nat Genet; 2010 Jul; 42(7):558-60. PubMed ID: 20581876
[TBL] [Abstract][Full Text] [Related]
49. One thousand genomes imputation in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium aggressive prostate cancer genome-wide association study.
Machiela MJ; Chen C; Liang L; Diver WR; Stevens VL; Tsilidis KK; Haiman CA; Chanock SJ; Hunter DJ; Kraft P;
Prostate; 2013 May; 73(7):677-89. PubMed ID: 23255287
[TBL] [Abstract][Full Text] [Related]
50. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
Lindstrom S; Schumacher F; Siddiq A; Travis RC; Campa D; Berndt SI; Diver WR; Severi G; Allen N; Andriole G; Bueno-de-Mesquita B; Chanock SJ; Crawford D; Gaziano JM; Giles GG; Giovannucci E; Guo C; Haiman CA; Hayes RB; Halkjaer J; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Navarro C; Riboli E; Sacerdote C; Stampfer M; Stram DO; Thun MJ; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Henderson B; Ma J; Le Marchand L; Albanes D; Kraft P
PLoS One; 2011 Feb; 6(2):e17142. PubMed ID: 21390317
[TBL] [Abstract][Full Text] [Related]
51. Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study.
Mhatre S; Wang Z; Nagrani R; Badwe R; Chiplunkar S; Mittal B; Yadav S; Zhang H; Chung CC; Patil P; Chanock S; Dikshit R; Chatterjee N; Rajaraman P
Lancet Oncol; 2017 Apr; 18(4):535-544. PubMed ID: 28274756
[TBL] [Abstract][Full Text] [Related]
52. The Cambridge Breast Intensity-modulated Radiotherapy Trial: patient- and treatment-related factors that influence late toxicity.
Barnett GC; Wilkinson JS; Moody AM; Wilson CB; Twyman N; Wishart GC; Burnet NG; Coles CE
Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):662-73. PubMed ID: 21646002
[TBL] [Abstract][Full Text] [Related]
53. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Wang X; Pankratz VS; Fredericksen Z; Tarrell R; Karaus M; McGuffog L; Pharaoh PD; Ponder BA; Dunning AM; Peock S; Cook M; Oliver C; Frost D; ; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Houdayer C; ; Hogervorst FB; Hooning MJ; Ligtenberg MJ; ; Spurdle A; Chenevix-Trench G; ; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Domchek SM; Nathanson KL; Rebbeck TR; Singer CF; Gschwantler-Kaulich D; Dressler C; Fink A; Szabo CI; Zikan M; Foretova L; Claes K; Thomas G; Hoover RN; Hunter DJ; Chanock SJ; Easton DF; Antoniou AC; Couch FJ
Hum Mol Genet; 2010 Jul; 19(14):2886-97. PubMed ID: 20418484
[TBL] [Abstract][Full Text] [Related]
54. A genome wide meta-analysis study for identification of common variation associated with breast cancer prognosis.
Rafiq S; Khan S; Tapper W; Collins A; Upstill-Goddard R; Gerty S; Blomqvist C; Aittomäki K; Couch FJ; Liu J; Nevanlinna H; Eccles D
PLoS One; 2014; 9(12):e101488. PubMed ID: 25526632
[TBL] [Abstract][Full Text] [Related]
55. Volumetric-Modulated Arc Radiotherapy with Daily Image-Guidance Carries Better Toxicity Profile for Higher Risk Prostate Cancer.
Ghanem AI; Elsaid AA; Elshaikh MA; Khedr GA
Asian Pac J Cancer Prev; 2021 Jan; 22(1):61-68. PubMed ID: 33507680
[TBL] [Abstract][Full Text] [Related]
56. Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial.
Leite ETT; Ramos CCA; Ribeiro VAB; Salvajoli BP; Nahas WC; Salvajoli JV; Ynoe Moraes F
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1263-1270. PubMed ID: 33346091
[TBL] [Abstract][Full Text] [Related]
57. Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity.
Franco NR; Massi MC; Ieva F; Manzoni A; Paganoni AM; Zunino P; Veldeman L; Ost P; Fonteyne V; Talbot CJ; Rattay T; Webb A; Johnson K; Lambrecht M; Haustermans K; De Meerleer G; de Ruysscher D; Vanneste B; Van Limbergen E; Choudhury A; Elliott RM; Sperk E; Veldwijk MR; Herskind C; Avuzzi B; Noris Chiorda B; Valdagni R; Azria D; Farcy-Jacquet MP; Brengues M; Rosenstein BS; Stock RG; Vega A; Aguado-Barrera ME; Sosa-Fajardo P; Dunning AM; Fachal L; Kerns SL; Payne D; Chang-Claude J; Seibold P; West CML; Rancati T;
Radiother Oncol; 2021 Jun; 159():241-248. PubMed ID: 33838170
[TBL] [Abstract][Full Text] [Related]
58. Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility.
Sehrawat B; Sridharan M; Ghosh S; Robson P; Cass CE; Mackey JR; Greiner R; Damaraju S
Hum Genet; 2011 Oct; 130(4):529-37. PubMed ID: 21424380
[TBL] [Abstract][Full Text] [Related]
59. Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort.
Goh CL; Saunders EJ; Leongamornlert DA; Tymrakiewicz M; Thomas K; Selvadurai ED; Woode-Amissah R; Dadaev T; Mahmud N; Castro E; Olmos D; Guy M; Govindasami K; O'Brien LT; Hall AL; Wilkinson RA; Sawyer EJ; Al Olama AA; Easton DF; Kote-Jarai Z; Parker CC; Eeles RA
BJU Int; 2013 Sep; 112(5):666-73. PubMed ID: 23320731
[TBL] [Abstract][Full Text] [Related]
60. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.
Kim S; Shin C; Jee SH
Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
